Germano Geno J 4
4 · Sage Therapeutics, Inc. · Filed Jun 11, 2021
Insider Transaction Report
Form 4
Germano Geno J
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-10+10,000→ 10,000 totalExercise: $76.09Exp: 2031-06-10→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan in accordance with the terms of the Amended and Restated Non-Employee Director Compensation Policy. The option will vest in full upon the earlier to occur of June 10, 2022 or the day immediately prior to the 2022 Annual Meeting of Sage's stockholders, subject to continued service as a director on such date.